Tag: Sphere-9
Medtronic announces new clinical data on Affera ablation technologies
Medtronic has announced continued momentum regarding its Affera family of technologies for cardiac arrhythmia treatment, including promising data presented at the Heart Rhythm Society...
Medtronic announces first patient enrolment in trial assessing VT treatment with...
Medtronic recently announced that the first patient has been enrolled in a US Food and Drug Administration (FDA) early feasibility study evaluating the Affera...
Texas Cardiac Arrhythmia Institute becomes first in USA to use FDA-approved...
Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St David's Medical Center (Austin, USA) recently became the first in the USA to use...